nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.151	0.225	CbGbCtD
Felbamate—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.111	0.166	CbGbCtD
Felbamate—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.111	0.166	CbGbCtD
Felbamate—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0708	0.106	CbGbCtD
Felbamate—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0478	0.0713	CbGbCtD
Felbamate—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0466	0.0695	CbGbCtD
Felbamate—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0456	0.068	CbGbCtD
Felbamate—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0407	0.0606	CbGbCtD
Felbamate—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0239	0.0356	CbGbCtD
Felbamate—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0225	0.0336	CbGbCtD
Felbamate—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00198	0.053	CbGpPWpGaD
Felbamate—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00175	0.0468	CbGpPWpGaD
Felbamate—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00143	0.0383	CbGpPWpGaD
Felbamate—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00108	0.0291	CbGpPWpGaD
Felbamate—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.000986	0.0265	CbGpPWpGaD
Felbamate—CYP2E1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000807	0.0216	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000789	0.0212	CbGpPWpGaD
Felbamate—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000787	0.0211	CbGpPWpGaD
Felbamate—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000725	0.0195	CbGpPWpGaD
Felbamate—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000717	0.0192	CbGpPWpGaD
Felbamate—CYP2E1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000675	0.0181	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000671	0.018	CbGpPWpGaD
Felbamate—CYP2E1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000649	0.0174	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000643	0.0173	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000593	0.0159	CbGpPWpGaD
Felbamate—CYP2E1—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000586	0.0157	CbGpPWpGaD
Felbamate—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000556	0.0149	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000547	0.0147	CbGpPWpGaD
Felbamate—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000521	0.014	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000504	0.0135	CbGpPWpGaD
Felbamate—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000501	0.0134	CbGpPWpGaD
Felbamate—CYP2E1—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00049	0.0132	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000484	0.013	CbGpPWpGaD
Felbamate—CYP2E1—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000472	0.0127	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000455	0.0122	CbGpPWpGaD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000441	0.0118	CbGpPWpGaD
Felbamate—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00148	CcSEcCtD
Felbamate—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00148	CcSEcCtD
Felbamate—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000431	0.0116	CbGpPWpGaD
Felbamate—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000428	0.00146	CcSEcCtD
Felbamate—Cough—Montelukast—chronic obstructive pulmonary disease	0.000428	0.00146	CcSEcCtD
Felbamate—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000426	0.00146	CcSEcCtD
Felbamate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000426	0.00146	CcSEcCtD
Felbamate—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000426	0.00146	CcSEcCtD
Felbamate—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000426	0.00146	CcSEcCtD
Felbamate—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000426	0.00146	CcSEcCtD
Felbamate—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000426	0.00146	CcSEcCtD
Felbamate—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000426	0.00146	CcSEcCtD
Felbamate—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000426	0.00146	CcSEcCtD
Felbamate—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000426	0.00146	CcSEcCtD
Felbamate—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000424	0.00145	CcSEcCtD
Felbamate—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000424	0.00145	CcSEcCtD
Felbamate—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000424	0.00145	CcSEcCtD
Felbamate—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000424	0.00145	CcSEcCtD
Felbamate—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000421	0.00144	CcSEcCtD
Felbamate—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000421	0.00144	CcSEcCtD
Felbamate—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.00143	CcSEcCtD
Felbamate—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000417	0.00143	CcSEcCtD
Felbamate—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000417	0.00143	CcSEcCtD
Felbamate—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000417	0.00143	CcSEcCtD
Felbamate—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000417	0.00143	CcSEcCtD
Felbamate—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000416	0.00142	CcSEcCtD
Felbamate—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000414	0.00142	CcSEcCtD
Felbamate—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00141	CcSEcCtD
Felbamate—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000412	0.00141	CcSEcCtD
Felbamate—GRIN2B—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000411	0.011	CbGpPWpGaD
Felbamate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000408	0.0014	CcSEcCtD
Felbamate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000408	0.0014	CcSEcCtD
Felbamate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000408	0.0014	CcSEcCtD
Felbamate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000408	0.0014	CcSEcCtD
Felbamate—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.0014	CcSEcCtD
Felbamate—Infection—Formoterol—chronic obstructive pulmonary disease	0.000406	0.00139	CcSEcCtD
Felbamate—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000406	0.00139	CcSEcCtD
Felbamate—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000402	0.00138	CcSEcCtD
Felbamate—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000402	0.00138	CcSEcCtD
Felbamate—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000402	0.00138	CcSEcCtD
Felbamate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000402	0.00138	CcSEcCtD
Felbamate—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000401	0.00137	CcSEcCtD
Felbamate—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.0004	0.00137	CcSEcCtD
Felbamate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.0004	0.00137	CcSEcCtD
Felbamate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.0004	0.00137	CcSEcCtD
Felbamate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000399	0.00136	CcSEcCtD
Felbamate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000399	0.00136	CcSEcCtD
Felbamate—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00136	CcSEcCtD
Felbamate—Infection—Montelukast—chronic obstructive pulmonary disease	0.000397	0.00136	CcSEcCtD
Felbamate—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000397	0.00136	CcSEcCtD
Felbamate—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00135	CcSEcCtD
Felbamate—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000392	0.00134	CcSEcCtD
Felbamate—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000391	0.00134	CcSEcCtD
Felbamate—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000387	0.00132	CcSEcCtD
Felbamate—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000387	0.0104	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000387	0.0104	CbGpPWpGaD
Felbamate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00132	CcSEcCtD
Felbamate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00132	CcSEcCtD
Felbamate—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.00131	CcSEcCtD
Felbamate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000382	0.00131	CcSEcCtD
Felbamate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000382	0.00131	CcSEcCtD
Felbamate—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000381	0.0013	CcSEcCtD
Felbamate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00038	0.0013	CcSEcCtD
Felbamate—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000378	0.0101	CbGpPWpGaD
Felbamate—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000378	0.00129	CcSEcCtD
Felbamate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00129	CcSEcCtD
Felbamate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000374	0.01	CbGpPWpGaD
Felbamate—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000373	0.00128	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.00127	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000372	0.00127	CcSEcCtD
Felbamate—GRIN2A—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000371	0.00994	CbGpPWpGaD
Felbamate—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000369	0.00126	CcSEcCtD
Felbamate—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000369	0.00126	CcSEcCtD
Felbamate—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.00126	CcSEcCtD
Felbamate—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000367	0.00126	CcSEcCtD
Felbamate—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000365	0.00125	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000364	0.00125	CcSEcCtD
Felbamate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00125	CcSEcCtD
Felbamate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00125	CcSEcCtD
Felbamate—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000364	0.00976	CbGpPWpGaD
Felbamate—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000363	0.00124	CcSEcCtD
Felbamate—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.00124	CcSEcCtD
Felbamate—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000362	0.00124	CcSEcCtD
Felbamate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00123	CcSEcCtD
Felbamate—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000359	0.00123	CcSEcCtD
Felbamate—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.00123	CcSEcCtD
Felbamate—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000359	0.00123	CcSEcCtD
Felbamate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000358	0.00122	CcSEcCtD
Felbamate—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000356	0.00122	CcSEcCtD
Felbamate—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000355	0.00121	CcSEcCtD
Felbamate—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000354	0.00121	CcSEcCtD
Felbamate—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000352	0.0012	CcSEcCtD
Felbamate—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000352	0.0012	CcSEcCtD
Felbamate—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000352	0.0012	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.0012	CcSEcCtD
Felbamate—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00119	CcSEcCtD
Felbamate—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00119	CcSEcCtD
Felbamate—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00119	CcSEcCtD
Felbamate—Pain—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00119	CcSEcCtD
Felbamate—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.00119	CcSEcCtD
Felbamate—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000348	0.00119	CcSEcCtD
Felbamate—CYP2E1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000347	0.0093	CbGpPWpGaD
Felbamate—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.00118	CcSEcCtD
Felbamate—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000345	0.00118	CcSEcCtD
Felbamate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00118	CcSEcCtD
Felbamate—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.00117	CcSEcCtD
Felbamate—Pain—Montelukast—chronic obstructive pulmonary disease	0.000342	0.00117	CcSEcCtD
Felbamate—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000341	0.00117	CcSEcCtD
Felbamate—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000341	0.00914	CbGpPWpGaD
Felbamate—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.00116	CcSEcCtD
Felbamate—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000339	0.00116	CcSEcCtD
Felbamate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000338	0.00116	CcSEcCtD
Felbamate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000338	0.00116	CcSEcCtD
Felbamate—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000337	0.00115	CcSEcCtD
Felbamate—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000336	0.00115	CcSEcCtD
Felbamate—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000336	0.00115	CcSEcCtD
Felbamate—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000336	0.00115	CcSEcCtD
Felbamate—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000335	0.00115	CcSEcCtD
Felbamate—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000335	0.00115	CcSEcCtD
Felbamate—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000335	0.00114	CcSEcCtD
Felbamate—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.00114	CcSEcCtD
Felbamate—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000334	0.00114	CcSEcCtD
Felbamate—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.00114	CcSEcCtD
Felbamate—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00113	CcSEcCtD
Felbamate—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00113	CcSEcCtD
Felbamate—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000327	0.00112	CcSEcCtD
Felbamate—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000327	0.00112	CcSEcCtD
Felbamate—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000326	0.00875	CbGpPWpGaD
Felbamate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000324	0.00111	CcSEcCtD
Felbamate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.00111	CcSEcCtD
Felbamate—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000323	0.0011	CcSEcCtD
Felbamate—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000323	0.0011	CcSEcCtD
Felbamate—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000323	0.0011	CcSEcCtD
Felbamate—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000323	0.0011	CcSEcCtD
Felbamate—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000322	0.0011	CcSEcCtD
Felbamate—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000322	0.0011	CcSEcCtD
Felbamate—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000319	0.00109	CcSEcCtD
Felbamate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000319	0.00109	CcSEcCtD
Felbamate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000319	0.00109	CcSEcCtD
Felbamate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000319	0.00109	CcSEcCtD
Felbamate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000318	0.00109	CcSEcCtD
Felbamate—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.00109	CcSEcCtD
Felbamate—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000317	0.00108	CcSEcCtD
Felbamate—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000317	0.00108	CcSEcCtD
Felbamate—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000316	0.00108	CcSEcCtD
Felbamate—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000316	0.00108	CcSEcCtD
Felbamate—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000316	0.00108	CcSEcCtD
Felbamate—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00108	CcSEcCtD
Felbamate—GRIN2B—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000315	0.00845	CbGpPWpGaD
Felbamate—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000313	0.0084	CbGpPWpGaD
Felbamate—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000313	0.00107	CcSEcCtD
Felbamate—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000311	0.00107	CcSEcCtD
Felbamate—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000311	0.00106	CcSEcCtD
Felbamate—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.00031	0.00106	CcSEcCtD
Felbamate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.00105	CcSEcCtD
Felbamate—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00104	CcSEcCtD
Felbamate—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00104	CcSEcCtD
Felbamate—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000301	0.00808	CbGpPWpGaD
Felbamate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000301	0.00103	CcSEcCtD
Felbamate—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.0003	0.00103	CcSEcCtD
Felbamate—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.0003	0.00805	CbGpPWpGaD
Felbamate—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000298	0.00102	CcSEcCtD
Felbamate—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000293	0.001	CcSEcCtD
Felbamate—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000293	0.001	CcSEcCtD
Felbamate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.000989	CcSEcCtD
Felbamate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000289	0.000989	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000987	CcSEcCtD
Felbamate—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000288	0.000987	CcSEcCtD
Felbamate—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000287	0.000982	CcSEcCtD
Felbamate—CYP2E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000287	0.00769	CbGpPWpGaD
Felbamate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000283	0.000968	CcSEcCtD
Felbamate—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000281	0.00754	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00028	0.00752	CbGpPWpGaD
Felbamate—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.000956	CcSEcCtD
Felbamate—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000279	0.000956	CcSEcCtD
Felbamate—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000277	0.000948	CcSEcCtD
Felbamate—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.000947	CcSEcCtD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000277	0.00742	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000275	0.00737	CbGpPWpGaD
Felbamate—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000274	0.000936	CcSEcCtD
Felbamate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.000933	CcSEcCtD
Felbamate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000272	0.0073	CbGpPWpGaD
Felbamate—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00027	0.000924	CcSEcCtD
Felbamate—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.000924	CcSEcCtD
Felbamate—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000264	0.000905	CcSEcCtD
Felbamate—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.000903	CcSEcCtD
Felbamate—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000261	0.007	CbGpPWpGaD
Felbamate—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00026	0.000888	CcSEcCtD
Felbamate—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.000888	CcSEcCtD
Felbamate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000257	0.000881	CcSEcCtD
Felbamate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.000881	CcSEcCtD
Felbamate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000257	0.00088	CcSEcCtD
Felbamate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000257	0.00088	CcSEcCtD
Felbamate—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000257	0.00088	CcSEcCtD
Felbamate—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.000875	CcSEcCtD
Felbamate—Headache—Formoterol—chronic obstructive pulmonary disease	0.000256	0.000875	CcSEcCtD
Felbamate—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000875	CcSEcCtD
Felbamate—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.000872	CcSEcCtD
Felbamate—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000872	CcSEcCtD
Felbamate—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00087	CcSEcCtD
Felbamate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000252	0.000863	CcSEcCtD
Felbamate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000252	0.000862	CcSEcCtD
Felbamate—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000252	0.00676	CbGpPWpGaD
Felbamate—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.00086	CcSEcCtD
Felbamate—Depression—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00086	CcSEcCtD
Felbamate—Headache—Montelukast—chronic obstructive pulmonary disease	0.000251	0.000857	CcSEcCtD
Felbamate—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00025	0.00671	CbGpPWpGaD
Felbamate—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000247	0.00664	CbGpPWpGaD
Felbamate—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.000839	CcSEcCtD
Felbamate—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000244	0.000836	CcSEcCtD
Felbamate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.000832	CcSEcCtD
Felbamate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.000831	CcSEcCtD
Felbamate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00083	CcSEcCtD
Felbamate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00083	CcSEcCtD
Felbamate—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.000827	CcSEcCtD
Felbamate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000238	0.000813	CcSEcCtD
Felbamate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.000801	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000234	0.00627	CbGpPWpGaD
Felbamate—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00023	0.000788	CcSEcCtD
Felbamate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.000784	CcSEcCtD
Felbamate—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000228	0.00078	CcSEcCtD
Felbamate—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000227	0.0061	CbGpPWpGaD
Felbamate—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000778	CcSEcCtD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000227	0.00609	CbGpPWpGaD
Felbamate—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000774	CcSEcCtD
Felbamate—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000225	0.00077	CcSEcCtD
Felbamate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.000757	CcSEcCtD
Felbamate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.000757	CcSEcCtD
Felbamate—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000221	0.00593	CbGpPWpGaD
Felbamate—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000219	0.00587	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000216	0.0058	CbGpPWpGaD
Felbamate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.000739	CcSEcCtD
Felbamate—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.000732	CcSEcCtD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000213	0.00572	CbGpPWpGaD
Felbamate—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000718	CcSEcCtD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000205	0.00549	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000204	0.00546	CbGpPWpGaD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000201	0.00539	CbGpPWpGaD
Felbamate—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.000684	CcSEcCtD
Felbamate—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000684	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000199	0.00535	CbGpPWpGaD
Felbamate—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000199	0.000679	CcSEcCtD
Felbamate—GRIN2B—EPH-Ephrin signaling—MMP9—chronic obstructive pulmonary disease	0.000192	0.00514	CbGpPWpGaD
Felbamate—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000647	CcSEcCtD
Felbamate—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000625	CcSEcCtD
Felbamate—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000182	0.000624	CcSEcCtD
Felbamate—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000623	CcSEcCtD
Felbamate—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000182	0.00488	CbGpPWpGaD
Felbamate—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000619	CcSEcCtD
Felbamate—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000608	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000176	0.00472	CbGpPWpGaD
Felbamate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.000601	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000175	0.0047	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—VEGFA—chronic obstructive pulmonary disease	0.000172	0.00462	CbGpPWpGaD
Felbamate—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000582	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.00017	0.00455	CbGpPWpGaD
Felbamate—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000574	CcSEcCtD
Felbamate—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000168	0.000574	CcSEcCtD
Felbamate—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000572	CcSEcCtD
Felbamate—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000567	CcSEcCtD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000165	0.00443	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.00431	CbGpPWpGaD
Felbamate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00055	CcSEcCtD
Felbamate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00055	CcSEcCtD
Felbamate—Infection—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000546	CcSEcCtD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000157	0.00421	CbGpPWpGaD
Felbamate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000537	CcSEcCtD
Felbamate—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000155	0.000532	CcSEcCtD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000155	0.00416	CbGpPWpGaD
Felbamate—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000524	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000149	0.00401	CbGpPWpGaD
Felbamate—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000501	CcSEcCtD
Felbamate—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.0005	CcSEcCtD
Felbamate—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000497	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000145	0.0039	CbGpPWpGaD
Felbamate—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000494	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000144	0.00385	CbGpPWpGaD
Felbamate—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000484	CcSEcCtD
Felbamate—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000478	CcSEcCtD
Felbamate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.000477	CcSEcCtD
Felbamate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.000477	CcSEcCtD
Felbamate—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000474	CcSEcCtD
Felbamate—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.000474	CcSEcCtD
Felbamate—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00047	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000136	0.00365	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000133	0.00357	CbGpPWpGaD
Felbamate—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000453	CcSEcCtD
Felbamate—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00045	CcSEcCtD
Felbamate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.000449	CcSEcCtD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00013	0.00349	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.00344	CbGpPWpGaD
Felbamate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000437	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000127	0.00342	CbGpPWpGaD
Felbamate—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000435	CcSEcCtD
Felbamate—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000435	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000121	0.00324	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000119	0.00319	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.00313	CbGpPWpGaD
Felbamate—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000395	CcSEcCtD
Felbamate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000389	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000112	0.00301	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000111	0.00297	CbGpPWpGaD
Felbamate—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000376	CcSEcCtD
Felbamate—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000364	CcSEcCtD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.00283	CbGpPWpGaD
Felbamate—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00035	CcSEcCtD
Felbamate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000347	CcSEcCtD
Felbamate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000346	CcSEcCtD
Felbamate—Headache—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000344	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000101	0.0027	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.93e-05	0.00266	CbGpPWpGaD
Felbamate—Nausea—Prednisone—chronic obstructive pulmonary disease	9.54e-05	0.000327	CcSEcCtD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.45e-05	0.00253	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	9.32e-05	0.0025	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.31e-05	0.0025	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	9.25e-05	0.00248	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.18e-05	0.00246	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	9.12e-05	0.00245	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.77e-05	0.00235	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.65e-05	0.00232	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—LEP—chronic obstructive pulmonary disease	8.46e-05	0.00227	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.87e-05	0.00211	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.76e-05	0.00208	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.66e-05	0.00205	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.66e-05	0.00205	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.13e-05	0.00191	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MMP9—chronic obstructive pulmonary disease	7.12e-05	0.00191	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	7.05e-05	0.00189	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.04e-05	0.00189	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.76e-05	0.00181	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.74e-05	0.00181	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.67e-05	0.00179	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.66e-05	0.00179	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—VEGFA—chronic obstructive pulmonary disease	6.4e-05	0.00172	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.76e-05	0.00154	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.6e-05	0.0015	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.52e-05	0.00148	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	5.44e-05	0.00146	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MMP9—chronic obstructive pulmonary disease	5.08e-05	0.00136	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.67e-05	0.00125	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.67e-05	0.00125	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.6e-05	0.00124	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.56e-05	0.00122	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	4.54e-05	0.00122	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—IL6—chronic obstructive pulmonary disease	4.42e-05	0.00119	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.29e-05	0.00115	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.23e-05	0.00114	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.23e-05	0.00113	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	4.19e-05	0.00112	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—EGFR—chronic obstructive pulmonary disease	4.11e-05	0.0011	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.07e-05	0.00109	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.01e-05	0.00108	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.91e-05	0.00105	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.88e-05	0.00104	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.6e-05	0.000967	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.57e-05	0.000959	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.51e-05	0.000941	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.27e-05	0.000878	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.26e-05	0.000875	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6—chronic obstructive pulmonary disease	3.16e-05	0.000847	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.6e-05	0.000697	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.48e-05	0.000666	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.45e-05	0.000658	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.24e-05	0.000601	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.17e-05	0.000582	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.11e-05	0.000566	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.06e-05	0.000554	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.96e-05	0.000526	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.92e-05	0.000514	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.89e-05	0.000508	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.77e-05	0.000474	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.73e-05	0.000464	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.72e-05	0.000462	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.7e-05	0.000455	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.59e-05	0.000427	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.58e-05	0.000424	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.5e-05	0.000402	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.33e-05	0.000356	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.31e-05	0.000351	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.22e-05	0.000327	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.00031	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.15e-05	0.000309	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.14e-05	0.000306	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.04e-05	0.000279	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	1.02e-05	0.000273	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.75e-06	0.000262	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.57e-06	0.000257	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.98e-06	0.000214	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.87e-06	0.000211	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	7.86e-06	0.000211	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	7.52e-06	0.000202	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.34e-06	0.000197	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.96e-06	0.000187	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.73e-06	0.000127	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.52e-06	0.000121	CbGpPWpGaD
